Finance

Lists
SVA:TSE
Sernova Biotherapeutics Inc
0,12 CA$
0,00%
(0,00) 1D
9 ოქტ, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
0,12 CA$
High
0,12 CA$
Low
0,12 CA$
Mkt. cap
41,53 მლნ.
Avg. vol.
353,07 ათ.
Volume
16,36 ათ.
52-wk high
0,20 CA$
52-wk low
0,08 CA$
EPS
-0,03 CA$
Beta
32,05
Shares outstanding
377,64 მლნ.
No. of employees
8
Open
0,12 CA$
High
0,12 CA$
Low
0,12 CA$
Mkt. cap
41,53 მლნ.
Avg. vol.
353,07 ათ.
Volume
16,36 ათ.
52-wk high
0,20 CA$
52-wk low
0,08 CA$
EPS
-0,03 CA$
Beta
32,05
Shares outstanding
377,64 მლნ.
No. of employees
8
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
7 საათის წინ
S&P 500: The Quick And Easy Days Are Over (SP500)
Yahoo Finance
Yahoo Finance
·
1 დღის წინ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
About Sernova Biotherapeutics Inc
CEOჯონათან რიგბი
Employees8
Founded2006
Headquartersლონდონი, ონტარიო, კანადა
Sector-
Last report
10 სექ. 2026
Fiscal period
Q3 2026
-0,01 CA$ / -0,00 CA$
-100,00%miss
Revenue / Est. (CAD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ოქტ. 2025
იან. 2026
აპრ. 2026
ივლ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
809,63 ათ.
434,15 ათ.
444,87 ათ.
432,62 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,59 მლნ.
1,68 მლნ.
1,85 მლნ.
1,69 მლნ.
Operating expense
2,40 მლნ.
2,12 მლნ.
2,30 მლნ.
2,12 მლნ.
Total operating expenses
2,40 მლნ.
2,12 მლნ.
2,30 მლნ.
2,12 მლნ.
Operating income
-2,40 მლნ.
-2,12 მლნ.
-2,30 მლნ.
-2,12 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-2,25 მლნ.
-2,41 მლნ.
-3,23 მლნ.
-2,57 მლნ.
EBT excluding unusual items
-2,26 მლნ.
-2,41 მლნ.
-3,23 მლნ.
-2,57 მლნ.
Income tax expense
-54,97 ათ.
-72,00 ათ.
-
-45,00 ათ.
Effective tax rate
2,44%
2,99%
-
1,75%
Other operating expenses
-
-
-
-
Net income
-2,20 მლნ.
-2,33 მლნ.
-3,23 მლნ.
-2,53 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,01
-0,01
-0,01
-0,01
Interest and investment income
260,60 ათ.
-
413,00
-
Interest expense
-
-477,12 ათ.
-920,95 ათ.
-260,18 ათ.
Net interest expenses
260,60 ათ.
-477,12 ათ.
-920,53 ათ.
-260,18 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,34 მლნ.
-2,11 მლნ.
-2,29 მლნ.
-2,11 მლნ.
Gain or loss from assets sale
-4,25 ათ.
-
-
-
AI content may include mistakes. Learn more
Google აპები